- socially bharat
- October 3, 2024
BioStock: Cereno’s phase IIa results positive, clear path forward
Thu, Oct 03, 2024 08:43 CET Report this content Recently, Cereno Scientific announced positive topline results from the
READ MORE
- socially bharat
- September 27, 2024
Cereno Scientific announces positive topline results of Phase IIa trial with lead candidate CS1 in Pulmonary Arterial Hypertension
Primary endpoint of safety and tolerability met successfully Positive impact on exploratory clinical efficacy parameters: REVEAL risk score: 43% (9/21) of